Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes

Clinical trial NCT01124656 · TERMINATED

Trial details

NCT number: NCT01124656
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-09-01
Primary completion: 2007-05-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.